Identification of pre-diagnostic lipid sets associated with liver cancer risk using untargeted lipidomics and chemical set analysis – a nested case-control study within the ATBC cohort

Accession: MTBLS7776
Source / host: MetaboLights — EBI MetaboLights FTP
Disease relevance: MASLD / NAFLD / NASH (category: Metabolomic, subtype: metabolomics/lipidomics)
Modality / assay: metabolomics
Platform: metabolite profiling; mass spectrometry; Liquid Chromatography MS - positive - reverse phase; Liquid Chromatography MS - negative - reverse phase
Organism: unspec
Size (indexed): 9.3 MB (9799064 bytes)
Downloaded bytes: 9.3 MB (9765857 bytes)
Access / raw: public / OPEN-raw

Download

Files

FileSizeSHA256
MTBLS7776.announcement.json613.9 KB22674ec5ad827a8d…
MTBLS7776.mhd.json3.8 MBf6041b9921906d08…
a_MTBLS7776_LC-MS_negative_reverse-phase_metabolite_profiling.txt498.2 KB5f26630ec60e69b1…
a_MTBLS7776_LC-MS_positive_reverse-phase_metabolite_profiling.txt502.2 KB5491d91b6a11b4b2…
i_Investigation.txt15.5 KB618e976ceb7945b6…
m_MTBLS7776_LC-MS_negative_reverse-phase_metabolite_profiling_v2_maf.tsv1.3 MB62326782b5e22ca1…
m_MTBLS7776_LC-MS_positive_reverse-phase_metabolite_profiling_v2_maf.tsv2.5 MB91e4151c6958a7b1…
s_MTBLS7776.txt158.4 KBd828fbf15c773be5…

Index note: public study (ISA-Tab+MAF)

Crawled by masld-atlas-crawler v1.0 at 2026-08-02T17:15:25Z.

About this dataset

This metabolite profiling; mass spectrometry; Liquid Chromatography MS - positive - reverse phase; Liquid Chromatography MS - negative - reverse phase dataset provides single-cell gene expression from unspec liver samples, with disease state recorded as MASLD/NAFLD/NASH. Beyond gene expression it includes a targeted gene panel.

Analyze it in Drylab

Open this dataset in Drylab and ask a question in plain language. The AI agent loads the files, runs the analysis in a ready sandbox and explains each result. A typical first pass:

  1. Load the filtered feature-barcode matrix (HDF5) and run quality control on counts, genes and mitochondrial reads per cell.
  2. Normalize, select variable genes, then cluster the cells and draw a UMAP.
  3. Annotate clusters with marker genes and compare the cell-type mix between conditions.
  4. Run differential expression between cell types or samples to characterize masld/nafld/nash biology.